{"name":"SV Life Sciences","permalink":"sv-life-sciences","crunchbase_url":"http://www.crunchbase.com/financial-organization/sv-life-sciences","homepage_url":"http://www.svlsa.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"650-571-8200","description":"Venture capital Firm","email_address":"info@svlsa.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Mon Apr 13 21:56:58 UTC 2009","updated_at":"Mon May 25 07:03:25 UTC 2009","overview":"<p>SV Life Sciences  is a venture capital adviser and manager that makes selected investments in entrepreneurs and management teams.</p>\n\n<p>SV Life Sciences provides finance to businesses at all stages of development and across the human life sciences sector. These sectors range from biotechnology &amp; pharmaceuticals to medical devices &amp; instruments, to healthcare information technology and services. SV Life Sciences currently advises or manages five funds with capital commitments of approximately $1.5 billion which primarily invest amounts of between $1m and $40m in North America and Europe, but will consider innovative investments in other regions. Our team of 34 professionals has a diverse, complimentary set of skills and experience that allow us to tailor a team to work with almost any life sciences business. </p>","image":{"available_sizes":[[[150,70],"assets/images/resized/0004/5361/45361v1-max-150x150.jpg"],[[250,117],"assets/images/resized/0004/5361/45361v1-max-250x250.jpg"],[[267,125],"assets/images/resized/0004/5361/45361v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"San Francisco ","address1":"Metro Center","address2":"950 Tower Lane, Suite 1725","zip_code":"94404","city":"Foster City","state_code":"CA","country_code":"USA","latitude":37.560116,"longitude":-122.275708}],"relationships":[{"is_past":false,"title":"Managing Partner","person":{"first_name":"Lutz","last_name":"Giebel","permalink":"lutz-giebel","image":{"available_sizes":[[[140,140],"assets/images/resized/0004/5364/45364v1-max-150x150.jpg"],[[140,140],"assets/images/resized/0004/5364/45364v1-max-250x250.jpg"],[[140,140],"assets/images/resized/0004/5364/45364v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Managing Partner","person":{"first_name":"Michael","last_name":"Ross","permalink":"michael-ross-2","image":{"available_sizes":[[[140,140],"assets/images/resized/0004/5367/45367v1-max-150x150.jpg"],[[140,140],"assets/images/resized/0004/5367/45367v1-max-250x250.jpg"],[[140,140],"assets/images/resized/0004/5367/45367v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Managing Partner","person":{"first_name":"Eugene","last_name":"Hill","permalink":"eugene-hill","image":{"available_sizes":[[[140,140],"assets/images/resized/0004/5366/45366v1-max-150x150.jpg"],[[140,140],"assets/images/resized/0004/5366/45366v1-max-250x250.jpg"],[[140,140],"assets/images/resized/0004/5366/45366v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Partner","person":{"first_name":"Paul","last_name":"LaViolette","permalink":"paul-laviolette","image":null}}],"investments":[{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2009/03/30/lensx-lasers-nabs-224m-for-eye-surgery-lasers/","source_description":"LensX Lasers nabs $22M for eye surgery lasers","raised_amount":22360000,"raised_currency_code":"USD","funded_year":2009,"funded_month":3,"funded_day":1,"company":{"name":"LensX Lasers","permalink":"lensx-lasers","image":{"available_sizes":[[[132,115],"assets/images/resized/0004/1073/41073v1-max-150x150.png"],[[132,115],"assets/images/resized/0004/1073/41073v1-max-250x250.png"],[[132,115],"assets/images/resized/0004/1073/41073v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"","source_description":"Capital Funding Report","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":6,"funded_day":12,"company":{"name":"EBR Systems","permalink":"ebr-systems","image":{"available_sizes":[[[150,30],"assets/images/resized/0004/5295/45295v1-max-150x150.png"],[[199,40],"assets/images/resized/0004/5295/45295v1-max-250x250.png"],[[199,40],"assets/images/resized/0004/5295/45295v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/sadra-medical-inc-series-c-30m/","source_description":"Sadra Medical, Inc.: Series C $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":22,"company":{"name":"Sadra Medical","permalink":"sadra-medica","image":{"available_sizes":[[[150,57],"assets/images/resized/0004/9189/49189v1-max-150x150.png"],[[171,66],"assets/images/resized/0004/9189/49189v1-max-250x250.png"],[[171,66],"assets/images/resized/0004/9189/49189v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.biospace.com/news_story.aspx?NewsEntityId=34039","source_description":" Sadra Medical Raises $19 Million In Series B Financing","raised_amount":19000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":10,"funded_day":23,"company":{"name":"Sadra Medical","permalink":"sadra-medica","image":{"available_sizes":[[[150,57],"assets/images/resized/0004/9189/49189v1-max-150x150.png"],[[171,66],"assets/images/resized/0004/9189/49189v1-max-250x250.png"],[[171,66],"assets/images/resized/0004/9189/49189v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://deals.venturebeat.com/2009/02/03/reshape-beefs-up-with-20m-to-bust-fat/","source_description":"ReShape beefs up with $20M to bust fat","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":2,"funded_day":3,"company":{"name":"ReShape Medical","permalink":"reshape-medical","image":{"available_sizes":[[[150,74],"assets/images/resized/0004/9666/49666v2-max-150x150.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-250x250.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.bizjournals.com/sanfrancisco/stories/2009/03/30/daily14.html","source_description":"Sutro Biopharma lands $15M with protein production","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":3,"funded_day":30,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.bizjournals.com/boston/stories/2009/03/16/daily8.html","source_description":"NKT Therapeutics launches with $8M","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":3,"funded_day":16,"company":{"name":"NKT Therapeutics","permalink":"nkt-therapeutics","image":{"available_sizes":[[[150,20],"assets/images/resized/0004/9825/49825v1-max-150x150.jpg"],[[250,33],"assets/images/resized/0004/9825/49825v1-max-250x250.jpg"],[[450,60],"assets/images/resized/0004/9825/49825v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/esbatech-rounds-additional-22m-series-b/2008-08-07","source_description":"ESBATech rounds up $22M in second round","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":7,"company":{"name":"ESBATech","permalink":"esbatech","image":{"available_sizes":[[[150,54],"assets/images/resized/0005/0466/50466v1-max-150x150.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-250x250.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/i-therapeutix-inc-series-c-15m/","source_description":"I-Therapeutix, Inc.: Series C $15M","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":24,"company":{"name":"Ocular Therapeutix","permalink":"itherapeutix","image":{"available_sizes":[[[150,74],"assets/images/resized/0005/0541/50541v3-max-150x150.jpg"],[[250,124],"assets/images/resized/0005/0541/50541v3-max-250x250.jpg"],[[360,179],"assets/images/resized/0005/0541/50541v3-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.freshnews.com/news/200168/cadent-closes-15-million-funding-round","source_description":"Cadent Closes $15 Million Funding Round","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":24,"company":{"name":"Cadent","permalink":"cadent","image":{"available_sizes":[[[150,51],"assets/images/resized/0005/7484/57484v1-max-150x150.png"],[[190,65],"assets/images/resized/0005/7484/57484v1-max-250x250.png"],[[190,65],"assets/images/resized/0005/7484/57484v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://deals.venturebeat.com/2007/12/10/fundamental-applied-biology-raises-21m-for-making-cell-free-proteins/","source_description":"Fundamental Applied Biology raises $21M for making â€œcell-freeâ€ proteins","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":12,"funded_day":10,"company":{"name":"Fundamental Applied Biology","permalink":"fundamental-applied-biology","image":{"available_sizes":[[[150,13],"assets/images/resized/0005/9799/59799v1-max-150x150.png"],[[242,22],"assets/images/resized/0005/9799/59799v1-max-250x250.png"],[[242,22],"assets/images/resized/0005/9799/59799v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://deals.venturebeat.com/2006/09/18/neovista-a-radiation-treatment-device-maker-to-raise-26m/","source_description":"NeoVista, a radiation treatment device maker, to raise $26M","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":9,"funded_day":18,"company":{"name":"NeoVista","permalink":"neovista","image":{"available_sizes":[[[150,102],"assets/images/resized/0005/9227/59227v1-max-150x150.jpg"],[[219,150],"assets/images/resized/0005/9227/59227v1-max-250x250.jpg"],[[219,150],"assets/images/resized/0005/9227/59227v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2006/12/08/neovista-a-co-targeting-age-related-macular-degeneration-raises-41m/","source_description":"NeoVista, a co. targeting age-related macular degeneration, raises $41M","raised_amount":41000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":12,"funded_day":8,"company":{"name":"NeoVista","permalink":"neovista","image":{"available_sizes":[[[150,102],"assets/images/resized/0005/9227/59227v1-max-150x150.jpg"],[[219,150],"assets/images/resized/0005/9227/59227v1-max-250x250.jpg"],[[219,150],"assets/images/resized/0005/9227/59227v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2009/10/19/lux-biosciences-scores-50m-series-b-for-eye-cure/","source_description":"Lux Biosciences scores $50M Series B for eye cure","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":null,"company":{"name":"Lux Biosciences","permalink":"lux-biosciences","image":{"available_sizes":[[[123,82],"assets/images/resized/0006/3157/63157v1-max-150x150.jpg"],[[123,82],"assets/images/resized/0006/3157/63157v1-max-250x250.jpg"],[[123,82],"assets/images/resized/0006/3157/63157v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/valentx-inc-series-b-203m/","source_description":"ValenTx, Inc.: Series B $20.3M","raised_amount":20300000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":1,"company":{"name":"ValenTx","permalink":"valentx","image":{"available_sizes":[[[150,58],"assets/images/resized/0006/3376/63376v1-max-150x150.jpg"],[[250,97],"assets/images/resized/0006/3376/63376v1-max-250x250.jpg"],[[336,131],"assets/images/resized/0006/3376/63376v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://news.morningstar.com/newsnet/ViewNews.aspx?article=/BW/20091117005641_univ.xml","source_description":"MorningStar","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":17,"company":{"name":"Entellus Medical","permalink":"entellus-medical","image":{"available_sizes":[[[150,41],"assets/images/resized/0006/6593/66593v1-max-150x150.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-250x250.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.splitrock.com/page/1/Entellus_15Mfinancing.jsp","source_description":"Split Rock Partners","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":5,"funded_day":29,"company":{"name":"Entellus Medical","permalink":"entellus-medical","image":{"available_sizes":[[[150,41],"assets/images/resized/0006/6593/66593v1-max-150x150.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-250x250.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.splitrock.com/page/1/Entellus-Bfinancing.jsp","source_description":"Split Rock Partners","raised_amount":3000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":4,"funded_day":1,"company":{"name":"Entellus Medical","permalink":"entellus-medical","image":{"available_sizes":[[[150,41],"assets/images/resized/0006/6593/66593v1-max-150x150.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-250x250.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.splitrock.com/page/1/Entellus-Bfinancing.jsp","source_description":"Split Rock Partners","raised_amount":9000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":1,"company":{"name":"Entellus Medical","permalink":"entellus-medical","image":{"available_sizes":[[[150,41],"assets/images/resized/0006/6593/66593v1-max-150x150.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-250x250.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/oxagen-rounds-26-7m-vc/2009-11-24?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Oxagen rounds up $26.7M in VC","raised_amount":26700000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":24,"company":{"name":"Oxagen","permalink":"oxagen","image":{"available_sizes":[[[150,45],"assets/images/resized/0006/7578/67578v1-max-150x150.png"],[[152,46],"assets/images/resized/0006/7578/67578v1-max-250x250.png"],[[152,46],"assets/images/resized/0006/7578/67578v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/ophthotech-nabs-30m-round-fund-amd-trial/2009-12-15?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Ophthotech nabs $30M round to fund AMD trial","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":15,"company":{"name":"Ophthotech","permalink":"ophthotech","image":{"available_sizes":[[[150,25],"assets/images/resized/0006/9859/69859v1-max-150x150.jpg"],[[250,42],"assets/images/resized/0006/9859/69859v1-max-250x250.jpg"],[[368,62],"assets/images/resized/0006/9859/69859v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/transenterix-inc-series-b-55m/","source_description":"TransEnterix, Inc.: Series B $55M","raised_amount":55000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":21,"company":{"name":"TransEnterix","permalink":"transenterix","image":{"available_sizes":[[[150,32],"assets/images/resized/0007/4457/74457v1-max-150x150.jpg"],[[185,40],"assets/images/resized/0007/4457/74457v1-max-250x250.jpg"],[[185,40],"assets/images/resized/0007/4457/74457v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/adimab-inc-series-d-82m/","source_description":"Adimab, Inc.: Series D $8.2M","raised_amount":8200000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":22,"company":{"name":"Adimab","permalink":"adimab","image":{"available_sizes":[[[150,80],"assets/images/resized/0007/4523/74523v1-max-150x150.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-250x250.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.adimab.com/adimab_pr_11_20_08.pdf","source_description":"Adimab, Inc. Announces Series C Financing","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":11,"funded_day":20,"company":{"name":"Adimab","permalink":"adimab","image":{"available_sizes":[[[150,80],"assets/images/resized/0007/4523/74523v1-max-150x150.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-250x250.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/01/uvaris-biotherapeutics-completes-second.html","source_description":"Juvaris BioTherapeutics Completes Second Close on $25M Series B Financing","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":27,"company":{"name":"Juvaris BioTherapeutics","permalink":"juvaris-biotherapeutics","image":{"available_sizes":[[[150,66],"assets/images/resized/0005/4084/54084v1-max-150x150.jpg"],[[214,95],"assets/images/resized/0005/4084/54084v1-max-250x250.jpg"],[[214,95],"assets/images/resized/0005/4084/54084v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://sec.gov/Archives/edgar/vprr/07/9999999997-07-041264","source_description":"SEC D","raised_amount":5900000,"raised_currency_code":"USD","funded_year":2007,"funded_month":9,"funded_day":21,"company":{"name":"Adimab","permalink":"adimab","image":{"available_sizes":[[[150,80],"assets/images/resized/0007/4523/74523v1-max-150x150.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-250x250.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://sutrobio.com/news/071210pr.html","source_description":"Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing Daniel S. Gold, PhD, Joins as Chief Executive Officer","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":12,"funded_day":10,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.researchviews.com/healthcare/medical/surgicalequipment/DealReport.aspx?DealID=36870&DealDate=5/11/2009+12:00:00+AM&Industry=Surgical+Equipment&Project=AE","source_description":"ReShape Medical Secures $3 Million in Series A Financing","raised_amount":3000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":8,"funded_day":31,"company":{"name":"ReShape Medical","permalink":"reshape-medical","image":{"available_sizes":[[[150,74],"assets/images/resized/0004/9666/49666v2-max-150x150.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-250x250.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":305000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":16,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/juvaris-biotherapeutics-inc-series-b-125m-2/","source_description":"Juvaris BioTherapeutics, Inc.: Series B $12.5M","raised_amount":12500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":12,"company":{"name":"Juvaris BioTherapeutics","permalink":"juvaris-biotherapeutics","image":{"available_sizes":[[[150,66],"assets/images/resized/0005/4084/54084v1-max-150x150.jpg"],[[214,95],"assets/images/resized/0005/4084/54084v1-max-250x250.jpg"],[[214,95],"assets/images/resized/0005/4084/54084v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://esbatech.com/pr/press_releases/esbatech_press_02082006.pdf","source_description":"ESBATech Closes USD 41M Series B Venture Financing","raised_amount":41000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":2,"company":{"name":"ESBATech","permalink":"esbatech","image":{"available_sizes":[[[150,54],"assets/images/resized/0005/0466/50466v1-max-150x150.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-250x250.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.neurotechusa.com/news_events/pr_2006-11-16.asp","source_description":"Neurotechâ„¢, Inc. Completes $35 Million Private Equity Financing","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":16,"company":{"name":"Neurotech","permalink":"neurotech","image":{"available_sizes":[[[150,47],"assets/images/resized/0008/4292/84292v1-max-150x150.jpg"],[[225,71],"assets/images/resized/0008/4292/84292v1-max-250x250.jpg"],[[225,71],"assets/images/resized/0008/4292/84292v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/story/catabasis-nails-39m-series-diabetes-programs/2010-04-21","source_description":"Catabasis lands $39M Series A for diabetes programs","raised_amount":39000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":21,"company":{"name":"Catabasis Pharmaceuticals","permalink":"catabasis-pharmaceuticals","image":{"available_sizes":[[[150,37],"assets/images/resized/0010/6512/106512v1-max-150x150.png"],[[250,62],"assets/images/resized/0010/6512/106512v1-max-250x250.png"],[[398,99],"assets/images/resized/0010/6512/106512v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"","source_description":"Cap Funding Report","raised_amount":1000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":1,"funded_day":1,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/logical-therapeutics-closes-16-9m-round-nsaid-program/2010-05-27?utm_medium=rss&utm_source=rss","source_description":"Logical Therapeutics closes $16.9M round for NSAID program","raised_amount":16900000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":27,"company":{"name":"Logical Therapeutics","permalink":"logical-therapeutics","image":{"available_sizes":[[[150,33],"assets/images/resized/0008/8366/88366v1-max-150x150.jpg"],[[250,55],"assets/images/resized/0008/8366/88366v1-max-250x250.jpg"],[[354,79],"assets/images/resized/0008/8366/88366v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/altura-medical-inc-series-a-20m/","source_description":"Altura Medical, Inc.: Series A $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":3,"company":{"name":"Altura Medical","permalink":"altura-medical","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.mpexpharma.com/pr_20050809.html","source_description":"Mpex Pharmaceuticals Closes $32 Million Series B Financing","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":8,"funded_day":9,"company":{"name":"Mpex Pharmaceuticals","permalink":"mpex-pharmaceuticals","image":{"available_sizes":[[[150,74],"assets/images/resized/0009/2230/92230v1-max-150x150.jpg"],[[185,92],"assets/images/resized/0009/2230/92230v1-max-250x250.jpg"],[[185,92],"assets/images/resized/0009/2230/92230v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/aquesys-inc-series-c-35m/","source_description":"AqueSys, Inc.: Series C $35M","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":2,"company":{"name":"AqueSys","permalink":"aquesys","image":{"available_sizes":[[[150,35],"assets/images/resized/0009/2422/92422v1-max-150x150.png"],[[215,51],"assets/images/resized/0009/2422/92422v1-max-250x250.png"],[[215,51],"assets/images/resized/0009/2422/92422v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.goodstartgenetics.com/images/PressReleases/goodstartgeneticspressrelease09102010.pdf","source_description":"Good Start Genetics, Inc. Raises $18 Million to Develop and Launch Sequencingâ€Based Preâ€Pregnancy Genetic Screening Test","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":10,"company":{"name":"Good Start Genetics","permalink":"good-start-genetics","image":{"available_sizes":[[[107,75],"assets/images/resized/0010/1463/101463v1-max-150x150.png"],[[107,75],"assets/images/resized/0010/1463/101463v1-max-250x250.png"],[[107,75],"assets/images/resized/0010/1463/101463v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2010/10/convergence-pharmaceuticals-raises-354m.html","source_description":"Convergence Pharmaceuticals Raises $35.4M in Series A Financing","raised_amount":35400000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":5,"company":{"name":"Convergence Pharmaceuticals","permalink":"convergence-pharmaceuticals","image":{"available_sizes":[[[150,31],"assets/images/resized/0010/4669/104669v1-max-150x150.png"],[[250,51],"assets/images/resized/0010/4669/104669v1-max-250x250.png"],[[385,80],"assets/images/resized/0010/4669/104669v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2010/11/delenex-therapeutics-closes-chf135m.html","source_description":"Delenex Therapeutics Closes CHF13.5M Series A Venture Capital Financing Round","raised_amount":14000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":12,"company":{"name":"Delenex Therapeutics","permalink":"delenex-therapeutics","image":{"available_sizes":[[[150,32],"assets/images/resized/0011/0186/110186v1-max-150x150.png"],[[250,54],"assets/images/resized/0011/0186/110186v1-max-250x250.png"],[[251,55],"assets/images/resized/0011/0186/110186v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2010/11/sutro-biopharma-secures-365m-in-series.html","source_description":"Sutro Biopharma Secures $36.5M in Series C Financing","raised_amount":36500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":17,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/01/panoptica-raises-30m-in-series.html","source_description":"PanOptica Raises $30m in Series A Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":4,"company":{"name":"PanOptica","permalink":"panoptica","image":{"available_sizes":[[[150,56],"assets/images/resized/0011/6246/116246v1-max-150x150.png"],[[250,93],"assets/images/resized/0011/6246/116246v1-max-250x250.png"],[[277,104],"assets/images/resized/0011/6246/116246v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://finance.yahoo.com/news/CardioFocus-Inc-Raises-306-prnews-3740959625.html?x=0","source_description":"CardioFocus, Inc. Raises $30.6 Million in Private Financing","raised_amount":30600000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":28,"company":{"name":"CardioFocus","permalink":"cardiofocus","image":{"available_sizes":[[[150,67],"assets/images/resized/0012/4085/124085v1-max-150x150.jpg"],[[250,112],"assets/images/resized/0012/4085/124085v1-max-250x250.jpg"],[[322,145],"assets/images/resized/0012/4085/124085v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.news-medical.net/news/20110228/Arsanis-closes-Series-A-financing-for-2410-million.aspx","source_description":"Arsanis closes Series A financing for $10 million","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":28,"company":{"name":"Arsanis","permalink":"arsanis","image":{"available_sizes":[[[150,49],"assets/images/resized/0012/4388/124388v1-max-150x150.png"],[[248,82],"assets/images/resized/0012/4388/124388v1-max-250x250.png"],[[248,82],"assets/images/resized/0012/4388/124388v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/05/delenex-therapeutics-raises-19-3m.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Delenex Therapeutics Raises $19.3M","raised_amount":19300000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":3,"company":{"name":"Delenex Therapeutics","permalink":"delenex-therapeutics","image":{"available_sizes":[[[150,32],"assets/images/resized/0011/0186/110186v1-max-150x150.png"],[[250,54],"assets/images/resized/0011/0186/110186v1-max-250x250.png"],[[251,55],"assets/images/resized/0011/0186/110186v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/06/cyterix-pharmaceutics-raises-9-2m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Cyterix Pharmaceutics Raises $9.2M in Series A Financing","raised_amount":9200000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":7,"company":{"name":"Cyterix Pharmaceuticals","permalink":"cyterix-pharmaceuticals","image":{"available_sizes":[[[150,41],"assets/images/resized/0013/8156/138156v1-max-150x150.png"],[[250,69],"assets/images/resized/0013/8156/138156v1-max-250x250.png"],[[280,78],"assets/images/resized/0013/8156/138156v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.vantiatherapeutics.com/news/news/vantia_pr_060711.pdf","source_description":"Vantia Therapeutics Raises Â£4 Million to Fund Clinical Development of its Lead Compounds","raised_amount":6500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":6,"company":{"name":"Vantia Therapeutics","permalink":"vantia-therapeutics","image":{"available_sizes":[[[150,59],"assets/images/resized/0014/2809/142809v1-max-150x150.png"],[[247,98],"assets/images/resized/0014/2809/142809v1-max-250x250.png"],[[247,98],"assets/images/resized/0014/2809/142809v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.finsmes.com/2011/08/entellus-medical-completes-35m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Entellus Medical Completes $35M Funding Round","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":17,"company":{"name":"Entellus Medical","permalink":"entellus-medical","image":{"available_sizes":[[[150,41],"assets/images/resized/0006/6593/66593v1-max-150x150.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-250x250.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.prnewswire.com/news-releases/kalvista-pharmaceuticals-launched-with-8-million-in-series-a-funding-to-develop-novel-class-of-drugs-for-diabetic-macular-edema-128230123.html","source_description":"KalVista Pharmaceuticals Launched With Â£8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema","raised_amount":8000000,"raised_currency_code":"GBP","funded_year":2011,"funded_month":8,"funded_day":23,"company":{"name":"KalVista Pharmaceuticals","permalink":"kalvista-pharmaceuticals","image":{"available_sizes":[[[150,132],"assets/images/resized/0015/0686/150686v1-max-150x150.jpg"],[[187,165],"assets/images/resized/0015/0686/150686v1-max-250x250.jpg"],[[187,165],"assets/images/resized/0015/0686/150686v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.afnm.com/news/affinium-news-082911.htm","source_description":"Affinium Pharmaceuticals Announces the Closing of $15 Million Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":29,"company":{"name":"Affinium Pharmaceuticals","permalink":"affinium-pharmaceuticals","image":{"available_sizes":[[[150,55],"assets/images/resized/0015/1756/151756v1-max-150x150.png"],[[250,93],"assets/images/resized/0015/1756/151756v1-max-250x250.png"],[[260,97],"assets/images/resized/0015/1756/151756v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.finsmes.com/2011/09/cardiokinetix-raises-44m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"CardioKinetix Raises $44M in Series E Financing","raised_amount":44000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":21,"company":{"name":"CardioKinetix","permalink":"cardiokinetix","image":{"available_sizes":[[[150,19],"assets/images/resized/0015/5136/155136v1-max-150x150.png"],[[250,32],"assets/images/resized/0015/5136/155136v1-max-250x250.png"],[[250,32],"assets/images/resized/0015/5136/155136v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.businesswire.com/news/home/20111019006928/en/Imagen-Biotech-Secures-40-Million-Advance-Ophthalmology","source_description":"Imagen Biotech Secures Up to $40 Million to Advance Ophthalmology Therapies","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":19,"company":{"name":"Imagen Biotech","permalink":"imagen-biotech","image":{"available_sizes":[[[150,62],"assets/images/resized/0015/8856/158856v1-max-150x150.jpg"],[[250,104],"assets/images/resized/0015/8856/158856v1-max-250x250.jpg"],[[402,168],"assets/images/resized/0015/8856/158856v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.rempexpharma.com/news/11-9-11","source_description":"Rempex Announces Series B Financing of up to $67.5 Million","raised_amount":67500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":9,"company":{"name":"Rempex Pharmaceuticals","permalink":"rempex-pharmaceuticals","image":{"available_sizes":[[[150,33],"assets/images/resized/0016/1699/161699v1-max-150x150.png"],[[250,55],"assets/images/resized/0016/1699/161699v1-max-250x250.png"],[[276,61],"assets/images/resized/0016/1699/161699v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://www.finsmes.com/2011/11/acufocus-closes-65m-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"AcuFocus Closes $65M Financing","raised_amount":65000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":29,"company":{"name":"AcuFocus","permalink":"acufocus","image":{"available_sizes":[[[150,51],"assets/images/resized/0016/4571/164571v1-max-150x150.png"],[[250,85],"assets/images/resized/0016/4571/164571v1-max-250x250.png"],[[296,101],"assets/images/resized/0016/4571/164571v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/12/topivert-raises-8m.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"TopiVert Raises £8M","raised_amount":8000000,"raised_currency_code":"GBP","funded_year":2011,"funded_month":12,"funded_day":6,"company":{"name":"TopiVert","permalink":"topivert","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://www.catabasispharma.com/pdfs/Catabasis_Final_Financing_PR_12.13.11.pdf","source_description":"Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":12,"funded_day":13,"company":{"name":"Catabasis Pharmaceuticals","permalink":"catabasis-pharmaceuticals","image":{"available_sizes":[[[150,37],"assets/images/resized/0010/6512/106512v1-max-150x150.png"],[[250,62],"assets/images/resized/0010/6512/106512v1-max-250x250.png"],[[398,99],"assets/images/resized/0010/6512/106512v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/12/csa-medical-raises-20-5m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"CSA Medical Raises $20.5M in Series B Funding","raised_amount":20500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":12,"funded_day":15,"company":{"name":"CSA Medical","permalink":"csa-medical","image":{"available_sizes":[[[110,123],"assets/images/resized/0011/9033/119033v1-max-150x150.png"],[[110,123],"assets/images/resized/0011/9033/119033v1-max-250x250.png"],[[110,123],"assets/images/resized/0011/9033/119033v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/02/wellnow-urgent-care-launches-35m.html","source_description":"WellNow Urgent Care Launches with $35M","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":15,"company":{"name":"WellNow Urgent Care","permalink":"wellnow-urgent-care","image":{"available_sizes":[[[150,69],"assets/images/resized/0017/4477/174477v1-max-150x150.png"],[[250,115],"assets/images/resized/0017/4477/174477v1-max-250x250.png"],[[321,148],"assets/images/resized/0017/4477/174477v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.masshightech.com/stories/2012/04/02/daily4-AlloCure-raises-25M-round-for-kidney-disease-trial-.html","source_description":"AlloCure raises $25M round for kidney disease trial ","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":2,"company":{"name":"AlloCure","permalink":"allocure","image":{"available_sizes":[[[150,59],"assets/images/resized/0009/2698/92698v1-max-150x150.png"],[[250,98],"assets/images/resized/0009/2698/92698v1-max-250x250.png"],[[273,108],"assets/images/resized/0009/2698/92698v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.fiercebiotech.com/story/google-contributes-14m-round-fast-growing-adimab/2012-04-03","source_description":"Google contributes to $14M round for fast-growing Adimab","raised_amount":14000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":3,"company":{"name":"Adimab","permalink":"adimab","image":{"available_sizes":[[[150,80],"assets/images/resized/0007/4523/74523v1-max-150x150.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-250x250.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://finance.yahoo.com/news/sutro-closes-16-5-million-113000166.html","source_description":"Sutro Closes $16.5 Million Second Tranche of Series C Financing","raised_amount":16500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":8,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120906e896oaipx&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120906e896oaipx%26from%3dalert%26pid%3d32","source_description":"Karus Thera Picks Up $7.6M to Develop Two Preclinical Compounds","raised_amount":7600000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":6,"company":{"name":"Karus Therapeutics ","permalink":"karus-therapeutics","image":{"available_sizes":[[[150,59],"assets/images/resized/0021/0236/210236v1-max-150x150.jpg"],[[250,99],"assets/images/resized/0021/0236/210236v1-max-250x250.jpg"],[[261,104],"assets/images/resized/0021/0236/210236v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/10/cibiem-raises-10m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Cibiem Raises $10M in Series A Financing","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":17,"company":{"name":"Cibiem","permalink":"cibiem","image":{"available_sizes":[[[150,55],"assets/images/resized/0021/6153/216153v1-max-150x150.jpg"],[[250,91],"assets/images/resized/0021/6153/216153v1-max-250x250.jpg"],[[261,96],"assets/images/resized/0021/6153/216153v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/10/health-essentials-receives-growth-capital-investment.html","source_description":"Health Essentials Receives Growth Capital Investment","raised_amount":null,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":25,"company":{"name":"Health Essentials","permalink":"health-essentials","image":null}}},{"funding_round":{"round_code":"c","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020121023e8anshyya&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020121023e8anshyya%26from%3dalert%26pid%3d32","source_description":"Obesity-Device Maker ReShape Medical Raises More Than $15M of $20M Series C","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":23,"company":{"name":"ReShape Medical","permalink":"reshape-medical","image":{"available_sizes":[[[150,74],"assets/images/resized/0004/9666/49666v2-max-150x150.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-250x250.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"Life Sciences Fund V","funded_year":2010,"funded_month":6,"funded_day":30,"raised_amount":523000000,"raised_currency_code":"USD","source_url":"http://www.fiercebiotech.com/story/sv-life-sciences-flush-venture-cash-bullish-exit-deals/2010-06-30?utm_medium=rss&utm_source=rss","source_description":"SV Life Sciences flush with venture cash, bullish on exit deals  Read more: SV Life Sciences flush with venture cash, bullish on exit deals"}],"video_embeds":[],"external_links":[]}